| Authors: |
Ciwinska M; VIB-KULeuven Centre for Cancer Biology, Department of Oncology, Leuven, Belgium., Messal HA; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hristova HR; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lutz C; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bornes L; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Chalkiadakis T; Centre for Molecular Medicine, UMC Utrecht, Utrecht, the Netherlands., Harkes R; Bioimaging Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Langedijk NSM; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hutten SJ; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Menezes RX; Biostatistics Centre and Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Jonkers J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Prekovic S; Centre for Molecular Medicine, UMC Utrecht, Utrecht, the Netherlands., Simons BD; Gurdon Institute, University of Cambridge, Cambridge, UK. bds10@cam.ac.uk.; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. bds10@cam.ac.uk.; Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK. bds10@cam.ac.uk., Scheele CLGJ; VIB-KULeuven Centre for Cancer Biology, Department of Oncology, Leuven, Belgium. colinda.scheele@kuleuven.be., van Rheenen J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. j.v.rheenen@nki.nl. |
